# Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.

> **NCT00001730** · PHASE4 · COMPLETED · sponsor: **National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)** · enrollment: 20 (—)

## Conditions studied

- Hypothyroidism
- Thyroid Neoplasms

## Interventions

- **DRUG:** Thyrogen

## Key facts

- **NCT ID:** NCT00001730
- **Lead sponsor:** National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1997-12
- **Primary completion:** —
- **Final completion:** 2000-04
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001730

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001730, "Study of Radioiodine (131-I) Uptake Following Administration of Thyrogen and Hypothyroid States During Thyroid Hormone Withdrawal.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00001730. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*